|
End-of-day quote
Korea S.E.
2026-10-02
|
5-day change | 1st Jan Change | ||
| 21,150.00 KRW | -9.42% |
|
-15.40% | -82.38% |
| 08-22 | Orum Therapeutics Receives FDA Clearance Of IND Application For ORM-1153, A Novel CD123-GSPT1 Degrader-Antibody Conjugate | CI |
| 07-15 | Alert wrongly tagged to Orum Therapeutics withdrawn | RE |
Chart: Technical Analysis
Korea S.E.KRW
| Markets | Quality | ||
|---|---|---|---|
Korea S.E.
| A475830 | End-of-day quote |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 37,800 | 49,950 | 66,000 |
| Spread/Res. | -44.05% | -57.66% | -67.95% |
| Spread/Supp. | +23.11% | +23.11% | +9.53% |
| Support | 17,180 | 17,180 | 19,310 |
- Stock Market
- Stocks
- A475830 Stock
- Charts Orum Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
